4 completed. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
Follow Erosive Esophagitis: new trials by email Literature Review of Erosive Esophagitis trials Research Report on Erosive Esophagitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 20 mg Once Daily or Vonoprazan 20 mg Twice Daily Vonoprazan - Erosive Esophagitis, Heartburn | Phase 1 | Completed | Phathom Pharmaceuticals, Inc. | 15 | 2024-05-07 | 2025-03-25 |
| A Study to Evaluate the Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of Oral Doses of H008 H008, H008 placebo, Lansoprazole - Erosive Esophagitis | Phase 1 | Completed | Jiangsu Carephar Pharmaceutical Co., Ltd. | 24 | 2021-06-24 | 2023-12-15 |
| A Study to Compare the Pharmacokinetic Characteristics of CJ-12420 CJ-12420 formulation 2, CJ-12420 formulation 1 - Erosive Esophagitis | Phase 1 | Completed | HK inno.N Corporation | 12 | 2015-04-01 | 2016-12-16 |
| Sensory Evaluation of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets Dexlansoprazole - Gastroesophageal Reflux Disease, Erosive Esophagitis | Phase 1 | Completed | Takeda | 8 | 2014-02-01 | 2015-03-06 |
Heartburn (2) · Gastroesophageal Reflux (1)
Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Signs and Symptoms, Digestive (2) · Deglutition Disorders (1) · Digestive System Diseases (1) · Esophageal Diseases (1) · Esophageal Motility Disorders (1) · Gastrointestinal Diseases (1)
1-(5-(1H-indol-5-yl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine (1) · 1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine (1) · Dexlansoprazole (1) · Lansoprazole (1)
HK inno.N Corporation (1) · Jiangsu Carephar Pharmaceutical Co., Ltd. (1) · Phathom Pharmaceuticals, Inc. (1) · Takeda (1)
United States (3) · South Korea (1)
Min-Gul Kim, MD (1)